NCT05907304
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05907304
Title A Study to Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With RAS Q61X Mutations (SEACRAFT-1)
Acronym SEACRAFT-1
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Erasca, Inc.
Indications
Therapies
Age Groups: child | adult | senior
Covered Countries USA | GBR | CAN | AUS

Facility Status City State Zip Country Details
University of California, San Francisco San Francisco California 94143 United States Details
Yale Cancer Center New Haven Connecticut 06510 United States Details
Florida Cancer Specialists - Sarasota Sarasota Florida 34232 United States Details
Florida Cancer Specialists - St. Petersburg St. Petersburg Florida 33705 United States Details
Emory University School of Medicine Atlanta Georgia 30322 United States Details
Henry Ford Health System Detroit Michigan 48202 United States Details
Washington University School of Medicine St Louis Missouri 63110 United States Details
Comprehensive Cancer Center of Nevada (CCCN) Las Vegas Nevada 89169 United States Details
Oregon Health & Science University Portland Oregon 97239 United States Details
SCRI Oncology Partners (formerly Tennessee Oncology) Nashville Tennessee 37203 United States Details
The University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
Inova Schar Cancer Institute Fairfax Virginia 22031 United States Details
NEXT Virginia Fairfax Virginia 22031 United States Details
University of Wisconsin Madison Wisconsin 53792 United States Details
Macquarie University Macquarie Park New South Wales Australia Details
St. Vincent's Hospital Melbourne Victoria Australia Details
Linear Clinical Research, LTD Perth Australia Details
Cross Cancer Institute- Alberta Health Services (AHS) Edmonton Alberta T6G 1Z2 Canada Details
British Columbia Cancer Agency Vancouver British Columbia V5Z 4E6 Canada Details
London Regional Cancer Center London Ontario Canada Details
Princess Margaret Cancer Centre Toronto Ontario M5G 2M9 Canada Details
Inje University Haeundae Paik Hospital Busan Busan Gwang'yeogsi 48108 South Korea Details
Samsung Medical Center Seoul Seoul Teugbyeolsi 06351 South Korea Details
National Cancer Center Goyang-si South Korea Details
Seoul National University Hospital Bundang Gyeonggi-do South Korea Details
Seoul National University Hospital Seoul South Korea Details
The Catholic University Hospital Seoul South Korea Details
Sarah Cannon Research Institute - HCA Healthcare City of London London W1G 6AD United Kingdom Details
Beatson West of Scotland Cancer Center Glasgow United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field